BSE Live
Apr 20, 09:01Prev. Close
1997.35
Open Price
0.00
Bid Price (Qty.)
1965.00 (6)
Offer Price (Qty.)
2048.00 (5)
NSE Live
Apr 20, 09:00Prev. Close
1998.00
Open Price
1998.00
Bid Price (Qty.)
2018.00 (6)
Offer Price (Qty.)
1898.10 (7)
| Cash Flow of JB Chemicals and Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 877.11 | 738.34 | 527.04 | 471.29 | 593.71 | |
| Net CashFlow From Operating Activities | 884.03 | 789.03 | 628.64 | 147.10 | 335.43 | |
| Net Cash Used In Investing Activities | -289.93 | -412.45 | -955.88 | 4.18 | -230.68 | |
| Net Cash Used From Financing Activities | -574.27 | -374.08 | 343.41 | -137.85 | -86.90 | |
| Foreign Exchange Gains / Losses | -0.01 | -0.02 | 0.03 | 0.00 | 0.04 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 19.84 | 2.49 | 16.20 | 13.42 | 17.90 | |
| Cash And Cash Equivalents Begin of Year | 56.37 | 53.88 | 37.69 | 24.26 | 6.37 | |
| Cash And Cash Equivalents End Of Year | 76.21 | 56.37 | 53.88 | 37.69 | 24.26 |
22.03.2026
Sell-on-rise market? SBI Securities sees Nifty under pressure, picks two stocks for the week ahead
16.03.2026
05.03.2026
20.02.2026
20.01.2026
JB Chemicals Consolidated December 2025 Net Sales at Rs 1,064.72 crore, up 10.51% Y-o-Y
20.01.2026
JB Chemicals Standalone December 2025 Net Sales at Rs 990.91 crore, up 8.47% Y-o-Y
17.11.2025
JB Chemicals Consolidated September 2025 Net Sales at Rs 1,084.90 crore, up 8.42% Y-o-Y
12.11.2025
JB Chemicals Standalone September 2025 Net Sales at Rs 1,022.65 crore, up 7% Y-o-Y
12.02.2014
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth